Nom du produit:5-cyclopropyl-1,3,4-oxadiazole-2-carboxylate lithium salt

IUPAC Name:lithium(1+) 5-cyclopropyl-1,3,4-oxadiazole-2-carboxylate

CAS:1523571-22-3
Formule moléculaire:C6H5LiN2O3
Pureté:95%+
Numéro de catalogue:CM107123
Poids moléculaire:160.06

Unité d'emballage Stock disponible Prix($) Quantité
CM107123-250mg in stock Ľưư
CM107123-1g 1-2 Weeks ʼnǵŢŢ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1523571-22-3
Formule moléculaire:C6H5LiN2O3
Point de fusion:-
Code SMILES:O=C(C1=NN=C(C2CC2)O1)[O-].[Li+]
Densité:
Numéro de catalogue:CM107123
Poids moléculaire:160.06
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Oxadiazoles
Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.
Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.